Focal Salvage High Dose-Rate Brachytherapy for Locally Recurrent Prostate Cancer After Primary Radiation Therapy Failure: Results From a Prospective Clinical Trial.
CONCLUSIONS: Our results suggest that focal salvage HDR brachytherapy is well tolerated and promising. External validation is needed.
PMID: 30244878 [PubMed - in process]
Source: Health Physics - Category: Physics Authors: Murgic J, Morton G, Loblaw A, D'Alimonte L, Ravi A, Wronski M, Davidson M, Haider M, Commisso K, Zhang L, Chung HT Tags: Int J Radiat Oncol Biol Phys Source Type: research
More News: Brachytherapy | Cancer | Cancer & Oncology | Clinical Trials | External Beam Therapy | MRI Scan | Physics | Prostate Cancer | Radiation Therapy | Study | Toxicology | Ultrasound